APO Research
Talk to an analyst

APO RESEARCH · REPORT

Corticosteroid Medication

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Corticosteroid Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchCorticosteroid Medication Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Corticosteroid Medication Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Corticosteroid Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Corticosteroid Medication Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Corticosteroid Medication Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Corticosteroid Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Corticosteroid Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Corticosteroid Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Corticosteroid Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Corticosteroid Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Corticosteroid Medication include Zhejiang Xianju Pharmaceutical Co.,Ltd, Yangzi River Pharmaceutical Group, Shandong Xinhua Pharmaceutical Company Limited, Sanofi, Johnson & Johnson, Novartis, Merck, Tianjin Tianyao Pharmaceuticals Co., Ltd. and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Corticosteroid Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Corticosteroid Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Corticosteroid Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Corticosteroid Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Corticosteroid Medication Segment by Company

Zhejiang Xianju Pharmaceutical Co.,Ltd

Yangzi River Pharmaceutical Group

Shandong Xinhua Pharmaceutical Company Limited

Sanofi

Johnson & Johnson

Novartis

Merck

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Pfizer

GSK

Bayer

AstraZeneca

Sumitomo

LEO Pharma

Cipla

Abbott Laboratories

Corticosteroid Medication Segment by Type

Injections

Tablets

Eye Drops

Lotions, Creams, Ointments, or Gels

Capsules

Nasal or Mouth Sprays

Corticosteroid Medication Segment by Application

Clinic

Hospital

Pharmacy

Corticosteroid Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corticosteroid Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Corticosteroid Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corticosteroid Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Corticosteroid Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Corticosteroid Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Corticosteroid Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Corticosteroid Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Corticosteroid Medication Industry Trends Table 2. Corticosteroid Medication Industry Drivers Table 3. Corticosteroid Medication Industry Opportunities and Challenges Table 4. Corticosteroid Medication Industry Restraints Table 5. Global Corticosteroid Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Corticosteroid Medication Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Corticosteroid Medication Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Corticosteroid Medication Sales Market Share by Manufacturers Table 9. Global Corticosteroid Medication Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Corticosteroid Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Corticosteroid Medication Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Corticosteroid Medication Manufacturers, Product Type & Application Table 13. Global Corticosteroid Medication Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Corticosteroid Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injections Table 17. Major Manufacturers of Tablets Table 18. Major Manufacturers of Eye Drops Table 19. Major Manufacturers of Lotions, Creams, Ointments, or Gels Table 20. Major Manufacturers of Capsules Table 21. Major Manufacturers of Nasal or Mouth Sprays Table 22. Global Corticosteroid Medication Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Corticosteroid Medication Sales by Type (2021-2026) & (k units) Table 24. Global Corticosteroid Medication Sales by Type (2027-2032) & (k units) Table 25. Global Corticosteroid Medication Sales Market Share by Type (2021-2026) Table 26. Global Corticosteroid Medication Sales Market Share by Type (2027-2032) Table 27. Global Corticosteroid Medication Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Corticosteroid Medication Revenue by Type (2021-2026) & (k units) Table 29. Global Corticosteroid Medication Revenue by Type (2027-2032) & (k units) Table 30. Global Corticosteroid Medication Revenue Market Share by Type (2021-2026) Table 31. Global Corticosteroid Medication Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Hospital Table 34. Major Manufacturers of Pharmacy Table 35. Global Corticosteroid Medication Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Corticosteroid Medication Sales by Application (2021-2026) & (k units) Table 37. Global Corticosteroid Medication Sales by Application (2027-2032) & (k units) Table 38. Global Corticosteroid Medication Sales Market Share by Application (2021-2026) Table 39. Global Corticosteroid Medication Sales Market Share by Application (2027-2032) Table 40. Global Corticosteroid Medication Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Corticosteroid Medication Revenue by Application (2021-2026) & (k units) Table 42. Global Corticosteroid Medication Revenue by Application (2027-2032) & (k units) Table 43. Global Corticosteroid Medication Revenue Market Share by Application (2021-2026) Table 44. Global Corticosteroid Medication Revenue Market Share by Application (2027-2032) Table 45. Global Corticosteroid Medication Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Corticosteroid Medication Sales by Region (2021-2026) & (k units) Table 47. Global Corticosteroid Medication Sales Market Share by Region (2021-2026) Table 48. Global Corticosteroid Medication Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Corticosteroid Medication Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Corticosteroid Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Corticosteroid Medication Sales by Country (2021-2026) & (k units) Table 52. North America Corticosteroid Medication Sales by Country (2027-2032) & (k units) Table 53. Europe Corticosteroid Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Corticosteroid Medication Sales by Country (2021-2026) & (k units) Table 55. Europe Corticosteroid Medication Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Corticosteroid Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Corticosteroid Medication Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Corticosteroid Medication Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Corticosteroid Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Corticosteroid Medication Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Corticosteroid Medication Sales by Country (2027-2032) & (k units) Table 62. Global Corticosteroid Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Corticosteroid Medication Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Corticosteroid Medication Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Corticosteroid Medication Revenue Market Share by Region (2021-2026) Table 66. Global Corticosteroid Medication Revenue Market Share by Region (2027-2032) Table 67. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information Table 68. Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview Table 69. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product Portfolio Table 71. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Development Table 72. Yangzi River Pharmaceutical Group Company Information Table 73. Yangzi River Pharmaceutical Group Business Overview Table 74. Yangzi River Pharmaceutical Group Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Yangzi River Pharmaceutical Group Corticosteroid Medication Product Portfolio Table 76. Yangzi River Pharmaceutical Group Recent Development Table 77. Shandong Xinhua Pharmaceutical Company Limited Company Information Table 78. Shandong Xinhua Pharmaceutical Company Limited Business Overview Table 79. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product Portfolio Table 81. Shandong Xinhua Pharmaceutical Company Limited Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sanofi Corticosteroid Medication Product Portfolio Table 86. Sanofi Recent Development Table 87. Johnson & Johnson Company Information Table 88. Johnson & Johnson Business Overview Table 89. Johnson & Johnson Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Johnson & Johnson Corticosteroid Medication Product Portfolio Table 91. Johnson & Johnson Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Novartis Corticosteroid Medication Product Portfolio Table 96. Novartis Recent Development Table 97. Merck Company Information Table 98. Merck Business Overview Table 99. Merck Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Merck Corticosteroid Medication Product Portfolio Table 101. Merck Recent Development Table 102. Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information Table 103. Tianjin Tianyao Pharmaceuticals Co., Ltd. Business Overview Table 104. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product Portfolio Table 106. Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Pfizer Corticosteroid Medication Product Portfolio Table 111. Pfizer Recent Development Table 112. GSK Company Information Table 113. GSK Business Overview Table 114. GSK Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. GSK Corticosteroid Medication Product Portfolio Table 116. GSK Recent Development Table 117. Bayer Company Information Table 118. Bayer Business Overview Table 119. Bayer Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Bayer Corticosteroid Medication Product Portfolio Table 121. Bayer Recent Development Table 122. AstraZeneca Company Information Table 123. AstraZeneca Business Overview Table 124. AstraZeneca Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. AstraZeneca Corticosteroid Medication Product Portfolio Table 126. AstraZeneca Recent Development Table 127. Sumitomo Company Information Table 128. Sumitomo Business Overview Table 129. Sumitomo Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Sumitomo Corticosteroid Medication Product Portfolio Table 131. Sumitomo Recent Development Table 132. LEO Pharma Company Information Table 133. LEO Pharma Business Overview Table 134. LEO Pharma Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. LEO Pharma Corticosteroid Medication Product Portfolio Table 136. LEO Pharma Recent Development Table 137. Cipla Company Information Table 138. Cipla Business Overview Table 139. Cipla Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Cipla Corticosteroid Medication Product Portfolio Table 141. Cipla Recent Development Table 142. Abbott Laboratories Company Information Table 143. Abbott Laboratories Business Overview Table 144. Abbott Laboratories Corticosteroid Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Abbott Laboratories Corticosteroid Medication Product Portfolio Table 146. Abbott Laboratories Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Corticosteroid Medication Distributors List Table 150. Corticosteroid Medication Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Corticosteroid Medication Product Image Figure 2. Global Corticosteroid Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Corticosteroid Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Corticosteroid Medication Sales (2021-2032) & (k units) Figure 5. Global Corticosteroid Medication Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Corticosteroid Medication Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injections Image Figure 9. Tablets Image Figure 10. Eye Drops Image Figure 11. Lotions, Creams, Ointments, or Gels Image Figure 12. Capsules Image Figure 13. Nasal or Mouth Sprays Image Figure 14. Global Corticosteroid Medication Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Corticosteroid Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Corticosteroid Medication Sales Market Share by Type (2021-2032) Figure 17. Global Corticosteroid Medication Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Corticosteroid Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Corticosteroid Medication Revenue Market Share by Type (2021-2032) Figure 20. Clinic Image Figure 21. Hospital Image Figure 22. Pharmacy Image Figure 23. Global Corticosteroid Medication Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Corticosteroid Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Corticosteroid Medication Sales Market Share by Application (2021-2032) Figure 26. Global Corticosteroid Medication Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Corticosteroid Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Corticosteroid Medication Revenue Market Share by Application (2021-2032) Figure 29. North America Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Corticosteroid Medication Sales Market Share by Country (2021-2032) Figure 31. U.S. Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Corticosteroid Medication Sales Market Share by Country (2021-2032) Figure 36. Germany Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Corticosteroid Medication Sales Market Share by Country (2021-2032) Figure 43. China Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Corticosteroid Medication Sales Market Share by Country (2021-2032) Figure 51. Brazil Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Corticosteroid Medication Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Corticosteroid Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Corticosteroid Medication Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Corticosteroid Medication Revenue (2021-2032) & (US$ Million) Figure 62. North America Corticosteroid Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Corticosteroid Medication Revenue (2021-2032) & (US$ Million) Figure 64. Europe Corticosteroid Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Corticosteroid Medication Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Corticosteroid Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Corticosteroid Medication Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Corticosteroid Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Corticosteroid Medication Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Corticosteroid Medication Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Tablets
  • Eye Drops
  • Lotions, Creams, Ointments, or Gels
  • Capsules
  • Nasal or Mouth Sprays
Applications
  • Clinic
  • Hospital
  • Pharmacy
Companies covered
  • Zhejiang Xianju Pharmaceutical Co.,Ltd
  • Yangzi River Pharmaceutical Group
  • Shandong Xinhua Pharmaceutical Company Limited
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Tianjin Tianyao Pharmaceuticals Co., Ltd.
  • Pfizer
  • GSK
  • Bayer
  • AstraZeneca
  • Sumitomo
  • LEO Pharma
  • Cipla
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Corticosteroid Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Corticosteroid Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Corticosteroid Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Corticosteroid Medication Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Corticosteroid Medication Market Dynamics
  1. 2.1 Corticosteroid Medication Industry Trends
  2. 2.2 Corticosteroid Medication Industry Drivers
  3. 2.3 Corticosteroid Medication Industry Opportunities and Challenges
  4. 2.4 Corticosteroid Medication Industry Restraints
3 Corticosteroid Medication Market by Manufacturers
  1. 3.1 Global Corticosteroid Medication Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Corticosteroid Medication Sales by Manufacturers (2021-2026)
  3. 3.3 Global Corticosteroid Medication Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Corticosteroid Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Corticosteroid Medication Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Corticosteroid Medication Manufacturers, Product Type & Application
  7. 3.7 Global Corticosteroid Medication Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Corticosteroid Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Corticosteroid Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Corticosteroid Medication Tier 1, Tier 2, and Tier 3
4 Corticosteroid Medication Market by Type
  1. 4.1 Corticosteroid Medication Type Introduction
  2. 4.1.1 Injections
  3. 4.1.2 Tablets
  4. 4.1.3 Eye Drops
  5. 4.1.4 Lotions, Creams, Ointments, or Gels
  6. 4.1.5 Capsules
  7. 4.1.6 Nasal or Mouth Sprays
  8. 4.2 Global Corticosteroid Medication Sales by Type
  9. 4.2.1 Global Corticosteroid Medication Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Corticosteroid Medication Sales by Type (2021-2032)
  11. 4.2.3 Global Corticosteroid Medication Sales Market Share by Type (2021-2032)
  12. 4.3 Global Corticosteroid Medication Revenue by Type
  13. 4.3.1 Global Corticosteroid Medication Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Corticosteroid Medication Revenue by Type (2021-2032)
  15. 4.3.3 Global Corticosteroid Medication Revenue Market Share by Type (2021-2032)
5 Corticosteroid Medication Market by Application
  1. 5.1 Corticosteroid Medication Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.2 Global Corticosteroid Medication Sales by Application
  6. 5.2.1 Global Corticosteroid Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Corticosteroid Medication Sales by Application (2021-2032)
  8. 5.2.3 Global Corticosteroid Medication Sales Market Share by Application (2021-2032)
  9. 5.3 Global Corticosteroid Medication Revenue by Application
  10. 5.3.1 Global Corticosteroid Medication Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Corticosteroid Medication Revenue by Application (2021-2032)
  12. 5.3.3 Global Corticosteroid Medication Revenue Market Share by Application (2021-2032)
6 Global Corticosteroid Medication Sales by Region
  1. 6.1 Global Corticosteroid Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Corticosteroid Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Corticosteroid Medication Sales by Region (2021-2026)
  4. 6.2.2 Global Corticosteroid Medication Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Corticosteroid Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Corticosteroid Medication Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Corticosteroid Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Corticosteroid Medication Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Corticosteroid Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Corticosteroid Medication Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Corticosteroid Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Corticosteroid Medication Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Corticosteroid Medication Revenue by Region
  1. 7.1 Global Corticosteroid Medication Revenue by Region
  2. 7.1.1 Global Corticosteroid Medication Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Corticosteroid Medication Revenue by Region (2021-2026)
  4. 7.1.3 Global Corticosteroid Medication Revenue by Region (2027-2032)
  5. 7.1.4 Global Corticosteroid Medication Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Corticosteroid Medication Revenue (2021-2032)
  8. 7.2.2 North America Corticosteroid Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Corticosteroid Medication Revenue (2021-2032)
  11. 7.3.2 Europe Corticosteroid Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Corticosteroid Medication Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Corticosteroid Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Corticosteroid Medication Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Corticosteroid Medication Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju Pharmaceutical Co.,Ltd
  2. 8.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
  3. 8.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview
  4. 8.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product Portfolio
  6. 8.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
  7. 8.2 Yangzi River Pharmaceutical Group
  8. 8.2.1 Yangzi River Pharmaceutical Group Company Information
  9. 8.2.2 Yangzi River Pharmaceutical Group Business Overview
  10. 8.2.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangzi River Pharmaceutical Group Corticosteroid Medication Product Portfolio
  12. 8.2.5 Yangzi River Pharmaceutical Group Recent Developments
  13. 8.3 Shandong Xinhua Pharmaceutical Company Limited
  14. 8.3.1 Shandong Xinhua Pharmaceutical Company Limited Company Information
  15. 8.3.2 Shandong Xinhua Pharmaceutical Company Limited Business Overview
  16. 8.3.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product Portfolio
  18. 8.3.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Corticosteroid Medication Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Johnson & Johnson
  26. 8.5.1 Johnson & Johnson Company Information
  27. 8.5.2 Johnson & Johnson Business Overview
  28. 8.5.3 Johnson & Johnson Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Johnson & Johnson Corticosteroid Medication Product Portfolio
  30. 8.5.5 Johnson & Johnson Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Corticosteroid Medication Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Corticosteroid Medication Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 Tianjin Tianyao Pharmaceuticals Co., Ltd.
  44. 8.8.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information
  45. 8.8.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Business Overview
  46. 8.8.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product Portfolio
  48. 8.8.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Corticosteroid Medication Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 GSK
  56. 8.10.1 GSK Company Information
  57. 8.10.2 GSK Business Overview
  58. 8.10.3 GSK Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GSK Corticosteroid Medication Product Portfolio
  60. 8.10.5 GSK Recent Developments
  61. 8.11 Bayer
  62. 8.11.1 Bayer Company Information
  63. 8.11.2 Bayer Business Overview
  64. 8.11.3 Bayer Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Corticosteroid Medication Product Portfolio
  66. 8.11.5 Bayer Recent Developments
  67. 8.12 AstraZeneca
  68. 8.12.1 AstraZeneca Company Information
  69. 8.12.2 AstraZeneca Business Overview
  70. 8.12.3 AstraZeneca Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca Corticosteroid Medication Product Portfolio
  72. 8.12.5 AstraZeneca Recent Developments
  73. 8.13 Sumitomo
  74. 8.13.1 Sumitomo Company Information
  75. 8.13.2 Sumitomo Business Overview
  76. 8.13.3 Sumitomo Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sumitomo Corticosteroid Medication Product Portfolio
  78. 8.13.5 Sumitomo Recent Developments
  79. 8.14 LEO Pharma
  80. 8.14.1 LEO Pharma Company Information
  81. 8.14.2 LEO Pharma Business Overview
  82. 8.14.3 LEO Pharma Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 LEO Pharma Corticosteroid Medication Product Portfolio
  84. 8.14.5 LEO Pharma Recent Developments
  85. 8.15 Cipla
  86. 8.15.1 Cipla Company Information
  87. 8.15.2 Cipla Business Overview
  88. 8.15.3 Cipla Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cipla Corticosteroid Medication Product Portfolio
  90. 8.15.5 Cipla Recent Developments
  91. 8.16 Abbott Laboratories
  92. 8.16.1 Abbott Laboratories Company Information
  93. 8.16.2 Abbott Laboratories Business Overview
  94. 8.16.3 Abbott Laboratories Corticosteroid Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Abbott Laboratories Corticosteroid Medication Product Portfolio
  96. 8.16.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Corticosteroid Medication Value Chain Analysis
  2. 9.1.1 Corticosteroid Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Corticosteroid Medication Production Mode & Process
  6. 9.2 Corticosteroid Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Corticosteroid Medication Distributors
  9. 9.2.3 Corticosteroid Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst